Download Files:
Telotristat ethyl
SKU
HY-13055A-10 mg
Category Reference compound
Tags Cancer; Neurological Disease, Metabolic Enzyme/Protease, Tryptophan Hydroxylase
$120 – $1,150
Products Details
Product Description
– Telotristat ethyl (LX1032) is a novel, orally-delivered inhibitor of tryptophan hydroxylase that reduces serotonin production.
Web ID
– HY-13055A
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C27H26ClF3N6O3
References
– [1]Tamas Oravecz, et al. LX1606 (aka LX1032), a Novel Inhibitor of Serotonin Synthesis, Alleviates Development of Inflammatory Bowel Disease in a Preclinical Model.|[2]Margolis, K.G., et al., Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine. Gut, 2013.
CAS Number
– 1033805-22-9
Molecular Weight
– 574.98
Compound Purity
– 99.79
SMILES
– N[C@@H](CC1=CC=C(C2=NC(N)=NC(O[C@H](C3=CC=C(Cl)C=C3N4N=C(C)C=C4)C(F)(F)F)=C2)C=C1)C(OCC)=O
Clinical Information
– Launched
Research Area
– Cancer; Neurological Disease
Solubility
– DMSO : ≥ 101.5 mg/mL
Target
– Tryptophan Hydroxylase
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.